
Concanavalin A Hepatitis plant lectin
Concanavalin A (Con A) is a plant lectin that is purified from jack beans. Con A binds to the mannose residues of varied glycoproteins and prompts lymphocytes. When Con A is run to mice, liver injury that can depend upon the activation of T lymphocytes by macrophages occurs (Tiegs et al., 1992). As a result of this reality, the model could allow the study of the pathophysiology of immunologically mediated hepatic points, resembling AIH. TNF-α and IFN-γ play important roles in Con A–induced liver injury (Gantner et al., 1995; Kusters et al., 1996) and IL-10 prevents liver injury on this model (Di Marco et al., 1999; Louis et al., 1997). Blood ranges of IL-2, IL-4, and IFN-γ dramatically improve after administration of Con A (Wang et al., 2012). Essential drawbacks of this model embrace the dearth of circulating autoantibodies and quick hepatocyte damage following a single-dose Con A injection, which is not a typical attribute of persistent AIH.
Lectins as modulators of autophagy in most cancers immunotherapy
Concanavalin A prompts T cells and pure killer cells and triggers anticancer immune responses
Since ConA is a well-known T cell mitogen it would moreover set off anticancer immune responses by activating tumor specific CTLs. Actually, remedy of hepatoma-bearing mice (ML-14a cells) with ConA (7.5 mg/kg) strongly diminished liver tumor formation and prolonged survival, whereby 40% of the animals had been tumor free on the end of the experiment [8]. Lymphocytic infiltrates spherical tumor nodules had been seen in ConA-treated animals, suggesting T cell mediated responses. Actually, the depletion of CD8+ T cells completely abrogated the therapeutic outcomes of ConA, whereas the depletion of CD4+ T cells solely partly prevented ConA-mediated inhibition of tumor formation (Fig. 4A). In line with this study, ConA triggered CD4+ and CD8+ T cell activation in mice as confirmed by the upregulated expression of CD69 [74].
In addition to, ConA-treated mice contained elevated numbers of activated pure killer (NK) cells, T cells, and NK T cells, which confirmed sturdy cytotoxic train in opposition to murine lymphoma cells in ex vivo assays. That’s moreover translated proper right into a strongly diminished number of liver nodules upon ConA remedy of colon cancer-bearing mice (colon-26), an affect that was abrogated upon NK cell depletion (Fig. 4A). Of observe, NK cells in immunodeficient nude mice (lacking NKT and T cells) weren’t activated upon ConA remedy, suggesting a job of the adaptive immune system in activating NK cells [74].

Furthermore, all outcomes had been abrogated in IFNγ knock-out mice, displaying the importance of an full of life immune response. Nonetheless, the remedy with ConA of hepatoma-bearing SCID mice moreover significantly inhibited liver tumor formation, nevertheless solely on the best dose of 20 mg/kg [8]. As SCID mice lack purposeful lymphocytes, these info counsel a direct cytotoxic affect of ConA in the direction of the most cancers cells. Actually, ConA induced direct autophagy-dependent cell demise in these mice (see above paragraph about ConA and most cancers cell demise). Thus, ConA prompts CD8+ CTLs and NK cells that in the reduction of in vivo tumor progress and potentiate ex vivo tumor cell lysis (Fig. 4A).
![]() Recombinant Programmed Cell Death Protein 1 (PD1) |
|||
RPU53502-1mg | Biomatik Corporation | 1mg | EUR 2457 |
![]() Recombinant Programmed Cell Death Protein 1 (PD1) |
|||
RPU53502-50ug | Biomatik Corporation | 50ug | EUR 445.5 |
![]() Recombinant Programmed Cell Death Protein 1 (PD1) |
|||
RPU53816-100ug | Biomatik Corporation | 100ug | EUR 564.3 |
![]() Recombinant Programmed Cell Death Protein 1 (PD1) |
|||
RPU53816-1mg | Biomatik Corporation | 1mg | EUR 2501.2 |
![]() Recombinant Programmed Cell Death Protein 1 (PD1) |
|||
RPU53816-50ug | Biomatik Corporation | 50ug | EUR 453.2 |
![]() Recombinant Programmed Cell Death Protein 1 (PD1) |
|||
RPU58652-100ug | Biomatik Corporation | 100ug | EUR 604.8 |
![]() Recombinant Programmed Cell Death Protein 1 (PD1) |
|||
RPU58652-1mg | Biomatik Corporation | 1mg | EUR 2808 |
![]() Recombinant Programmed Cell Death Protein 1 (PD1) |
|||
RPU58652-50ug | Biomatik Corporation | 50ug | EUR 470.3 |
![]() Recombinant Programmed Cell Death Protein 6 (PDCD6) |
|||
4-RPL096Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Programmed Cell Death Protein 6 expressed in: E.coli |
![]() Recombinant Programmed Cell Death Protein 5 (PDCD5) |
|||
4-RPL105Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Programmed Cell Death Protein 5 expressed in: E.coli |
![]() Recombinant Programmed Cell Death Protein 1 (PDCD1) |
|||
4-RPA751Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Programmed Cell Death Protein 1 expressed in: E.coli |
![]() Recombinant Programmed Cell Death Protein 1 (PDCD1) |
|||
4-RPA751Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Programmed Cell Death Protein 1 expressed in: E.coli |
![]() Recombinant Programmed Cell Death Protein 6 (PDCD6) |
|||
RPU53272-100ug | Biomatik Corporation | 100ug | EUR 542.3 |
![]() Recombinant Programmed Cell Death Protein 6 (PDCD6) |
|||
RPU53272-1mg | Biomatik Corporation | 1mg | EUR 2402.4 |
![]() Recombinant Programmed Cell Death Protein 6 (PDCD6) |
|||
RPU53272-50ug | Biomatik Corporation | 50ug | EUR 435.6 |
![]() Recombinant Programmed Cell Death Protein 5 (PDCD5) |
|||
RPU52490-100ug | Biomatik Corporation | 100ug | EUR 528 |
![]() Recombinant Programmed Cell Death Protein 5 (PDCD5) |
|||
RPU52490-1mg | Biomatik Corporation | 1mg | EUR 2337.4 |
![]() Recombinant Programmed Cell Death Protein 5 (PDCD5) |
|||
RPU52490-50ug | Biomatik Corporation | 50ug | EUR 423.5 |
![]() Recombinant Human Programmed cell death protein 5 (PDCD5) |
|||
RPC21797-100ug | Biomatik Corporation | 100ug | EUR 460.9 |
![]() Recombinant Human Programmed cell death protein 5 (PDCD5) |
|||
RPC21797-1mg | Biomatik Corporation | 1mg | EUR 2237.8 |
![]() Recombinant Human Programmed cell death protein 5 (PDCD5) |
|||
RPC21797-20ug | Biomatik Corporation | 20ug | EUR 258.7 |
![]() Recombinant Human Programmed cell death protein 2 (PDCD2) |
|||
RPC28416-100ug | Biomatik Corporation | 100ug | EUR 635.8 |
![]() Recombinant Human Programmed cell death protein 2 (PDCD2) |
|||
RPC28416-1mg | Biomatik Corporation | 1mg | EUR 2885.2 |
![]() Recombinant Human Programmed cell death protein 2 (PDCD2) |
|||
RPC28416-20ug | Biomatik Corporation | 20ug | EUR 353.4 |
![]() PDCD5 Programmed Cell Death-5 Human Recombinant Protein |
|||
PROTO14737 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: PDCD5 Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 125 amino acids and having a molecular mass of 14 kDa. |
![]() Recombinant Human Programmed cell death protein 10 Protein, His-SUMO, E.coli-1mg |
|||
QP8043-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
![]() Recombinant Programmed Cell Death Protein 1 Ligand 1 (PDL1) |
|||
RPU43426-100ug | Biomatik Corporation | 100ug | EUR 554.4 |
![]() Recombinant Programmed Cell Death Protein 1 Ligand 1 (PDL1) |
|||
RPU43426-1mg | Biomatik Corporation | 1mg | EUR 2457 |
![]() Recombinant Programmed Cell Death Protein 1 Ligand 1 (PDL1) |
|||
RPU43426-50ug | Biomatik Corporation | 50ug | EUR 445.5 |
![]() Recombinant Programmed Cell Death Protein 1 Ligand 1 (PDL1) |
|||
RPU43427-100ug | Biomatik Corporation | 100ug | EUR 517 |
![]() Recombinant Programmed Cell Death Protein 1 Ligand 1 (PDL1) |
|||
RPU43427-1mg | Biomatik Corporation | 1mg | EUR 2293.2 |
![]() Recombinant Programmed Cell Death Protein 1 Ligand 1 (PDL1) |
|||
RPU43427-50ug | Biomatik Corporation | 50ug | EUR 415.8 |